Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6 in Inflammatory Bowel Disease
NCT06512441Recruiting
- Sponsor
- Changhai Hospital
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in inflammatory bowel disease (IBD) comparing Vitamin B6 Group with Placebo Group (2 arms). Primary endpoint: Clinical remission rate at 6 months. Started Jun 2024; status: recruiting.
02
Drugs
pyridoxine
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT06512441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06512441.